GGrantIndex
Sort

23,748 grants matching melanoma

Langerhans vs monocyte-derived dendritic cell vaccines

$362,675
Sloan-Kettering Institute For Cancer Res · R21 · FY2002 · CA

ENHANCED DEVELOPMENT OF THE XIPHOPHORUS MODEL SYSTEM

$362,608
Texas State University-San Marcos · R24 · FY2000 · RR

Novel therapeutics for targeting checkpoint dysfunction in cancer

$362,569
Weei-Chin Lin · Baylor College Of Medicine · R01 · FY2017 · CA

REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF

$362,569
Nicholas Mitsiades · Baylor College Of Medicine · R01 · FY2016 · CA

A novel T-cell subset able to kill relapsed cancers

$362,569
Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · CA

Novel therapeutics for targeting checkpoint dysfunction in cancer

$362,569
Weei-Chin Lin · Baylor College Of Medicine · R01 · FY2020 · CA

A novel T-cell subset able to kill relapsed cancers

$362,569
Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · CA

THE ROLE OF TELOMERASE REGULATORS IN TELOMERE MAINTENANCE AND GENOMIC INSTABILITY

$362,569
Zhou Songyang · Baylor College Of Medicine · R01 · FY2017 · CA

REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF

$362,569
Nicholas Mitsiades · Baylor College Of Medicine · R01 · FY2017 · CA

REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF

$362,569
Nicholas Mitsiades · Baylor College Of Medicine · R01 · FY2015 · CA

Novel therapeutics for targeting checkpoint dysfunction in cancer

$362,569
Weei-Chin Lin · Baylor College Of Medicine · R01 · FY2021 · CA

REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF

$362,569
Nicholas Mitsiades · Baylor College Of Medicine · R01 · FY2018 · CA

Identifying novel therapies targeting Merkel cell carcinoma and tumor microenvironment

$362,472
Ling Gao · Southern California Inst For Res/Educ · R01 · FY2024 · CA

Targeting Oncogenic BRAF And PI3'-Kinase Signaling For Melanoma Therapy

$362,392
Martin McMahon · University Of California, San Francisco · R01 · FY2013 · CA

Project 1: Siglec15 as a new target for lung cancer immunotherapy

$362,378
Lieping Chen · Yale University · P50 · FY2021 · CA

A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.

$362,340
David E Fisher · Massachusetts General Hospital · R01 · FY2019 · CA

Regulation of cell homeostasis by fbx4

$362,296
J. Alan Diehl · University Of Pennsylvania · R01 · FY2011 · CA

Regulation of cell homeostasis by fbx4

$362,296
J. Alan Diehl · University Of Pennsylvania · R01 · FY2012 · CA

MDA-7/IL-24: Therapy of Prostate Cancer

$362,273
Paul B Fisher · Columbia University Health Sciences · P01 · FY2007 · CA

Seeing Red: Recessive red pigeons as an innovative model to elucidate Sox10 function and evolution in vertebrate pigmentation

$362,211
Eric Domyan · Utah Valley University · R15 · FY2019 · GM

Effects of Radiation on Brain Microvasculature and Cognition

$362,161
William Edmund Sonntag · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2009 · NS

Role and mechanisms of IGF2BP1 in melanoma pathogenesis

$362,157
Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA

Role and mechanisms of IGF2BP1 in melanoma pathogenesis

$362,157
Vladimir S. Spiegelman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · CA

MECHANOSURVEILLANCE IN BREAST CANCER METASTASIS

$362,132
Ekrem Emrah Er · University Of Illinois At Chicago · R37 · FY2022 · CA

MECHANOSURVEILLANCE IN BREAST CANCER METASTASIS

$362,132
Ekrem Emrah Er · University Of Illinois At Chicago · R37 · FY2025 · CA